MedElevator Войти в исследования
← Поиск публикаций

DOI 10.3390/ijms231911418

Медицинская библиотека · International journal of molecular sciences · 2022

Migraine Pharmacological Treatment and Cognitive Impairment: Risks and Benefits.

Russo Mirella, De Rosa Matteo A, Calisi Dario, Consoli Stefano, Evangelista Giacomo, Dono Fedele, Santilli Matteo, Granzotto Alberto, Onofrj Marco, Sensi Stefano L

СтатьяОбзорПеревод пока не подготовлен

Аннотация

Migraine is a common neurological disorder impairing the quality of life of patients. The condition requires, as an acute or prophylactic line of intervention, the frequent use of drugs acting on the central nervous system (CNS). The long-term impact of these medications on cognition and neurodegeneration has never been consistently assessed. The paper reviews pharmacological migraine treatments and discusses their biological and clinical effects on the CNS. The different anti-migraine drugs show distinct profiles concerning neurodegeneration and the risk of cognitive deficits. These features should be carefully evaluated when prescribing a pharmacological treatment as many migraineurs are of scholar or working age and their performances may be affected by drug misuse. Thus, a reconsideration of therapy guidelines is warranted. Furthermore, since conflicting results have emerged in the relationship between migraine and dementia, future studies must consider present and past pharmacological regimens as potential confounding factors.

Для цитирования: Russo Mirella, De Rosa Matteo A, Calisi Dario, Consoli Stefano, Evangelista Giacomo, Dono Fedele, Santilli Matteo, Granzotto Alberto, Onofrj Marco, Sensi Stefano L. Migraine Pharmacological Treatment and Cognitive Impairment: Risks and Benefits.. International journal of molecular sciences. 2022. DOI: 10.3390/ijms231911418.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.